Plain-English translation of NCT05010863 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for specific proteins in blood that could help doctors detect gastric cancer (cancer of the stomach) at an earlier, more treatable stage. They will collect blood samples from people with early-stage gastric cancer, advanced gastric cancer, people with other types of cancer, and healthy volunteers to identify these protein markers and develop a test kit that could be used in the future.
Early detection of gastric cancer could save lives, but there are currently no simple blood tests to catch it early. This study is trying to find protein markers in blood that signal gastric cancer, which could eventually lead to an easier screening tool for patients at risk.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have one blood draw visit where medical staff will collect about 600 microliters (a small amount) of blood from your arm. The blood sample will be processed to separate serum and plasma, which researchers will then analyze using advanced technology to look for protein markers associated with gastric cancer. There is no ongoing treatment or follow-up required—this is a single sample collection visit.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China